Koss Olinger Consulting, LLC Co Diagnostics, Inc. Transaction History
Koss Olinger Consulting, LLC
- $1.14 Billion
- Q3 2024
A detailed history of Koss Olinger Consulting, LLC transactions in Co Diagnostics, Inc. stock. As of the latest transaction made, Koss Olinger Consulting, LLC holds 58,102 shares of CODX stock, worth $42,414. This represents 0.01% of its overall portfolio holdings.
Number of Shares
58,102
Previous 58,887
1.33%
Holding current value
$42,414
Previous $73,000
1.37%
% of portfolio
0.01%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding CODX
# of Institutions
43Shares Held
4.28MCall Options Held
48.2KPut Options Held
53.3K-
Vanguard Group Inc Valley Forge, PA1.78MShares$1.3 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny568KShares$414,4370.0% of portfolio
-
Black Rock Inc. New York, NY502KShares$366,4780.0% of portfolio
-
Geode Capital Management, LLC Boston, MA321KShares$234,5300.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX273KShares$199,2170.01% of portfolio
About Co-Diagnostics, Inc.
- Ticker CODX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 33,781,000
- Market Cap $24.7M
- Description
- Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...